摘要:
The invention relates to a novel sustained release pharmaceutical formulation adapted for administration by injection containing the compound 7α-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17β-diol, more particularly to a formulation adapted for administration by injection containing the compound 7α-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17β-diol in solution in a ricinoleate vehicle which additionally comprises at least one alcohol and a non-aqueous ester solvent which is miscible in the ricinoleate vehicle.
摘要:
Late season termination of reproductive plant growth of a plant having an indeterminate growth pattern is achieved by the application of a semicarbazone plant growth regulator to a locus of a growing plant at a time following peak bloom of the plant. The semicarbazone is applied as an active ingredient in an amount sufficient to terminate continued reproductive growth of the plant without substantially affecting mature reproductive growth existing on the plant at the time of application. Most preferably, the semicarbazone is diflufenzopyr.
摘要:
A light table is used in connection with an underlying portable light source to illuminate a pattern disposed between the light table and an overlying fabric sheet. The light table includes a portable frame which spaces a translucent upper plate from a lower supporting surface over the light source. The frame also includes a downwardly facing peripheral frame channel which is utilized to clamp the overlying fabric sheet to the light table. More particularly, a plurality of resilient, one-piece hold-down clamps are placed about the periphery of the light table to firmly hold portions of the fabric sheet to the table to minimize relative movement therebetween. The clamps include a lower bracket bent into a resilient arch. The clamps snap into place about the periphery of the light table such that the arch-like lower bracket cooperates with the peripheral frame channel.
摘要:
Process for preparing a freeze-dried, potential liposome, mixture which comprises either (a) dissolving at least one liposome-forming amphipathic lipid, at least one biologically-active compound, and optionally one or more adjuvants, in a suitable solvent, and then freeze-drying the solution, or (b) preparing by any known method an aqueous liposome composition containing at least one biologically-active compound, and then freeze-drying the said aqueous liposome composition. Process for preparing an aqueous liposome composition which comprises dispersing said freeze-dried, potential liposome, mixture, obtained by procedure (a) or (b), in a suitable aqueous medium.
摘要:
Vacuum regulator apparatus comprising: a valve that in use is arranged to admit air to a vacuum system that in operation is at a sub-atmospheric pressure, the apparatus being so arranged that an increase in the pressure in the vacuum system tends to cause less air to be admitted to the vacuum system by the regulator apparatus, and vice versa; means responsive to the position of the said valve arranged to give a first signal if air is being admitted at more than a first predetermined rate and a second signal if air is being admitted at less than a second predetermined rate lower than the first; and pressure-responsive means arranged to give a third signal if the pressure in the vacuum system is outside a predetermined range.
摘要:
The invention relates to a novel sustained release pharmaceutical formulation adapted for administration by injection containing the compound 7α-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17β-diol, more particularly to a formulation adapted for administration by injection containing the compound 7α-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17β-diol in solution in a ricinoleate vehicle which additionally comprises at least one alcohol and a non-aqueous ester solvent which is miscible in the ricinoleate vehicle.
摘要:
The invention relates to a novel sustained release pharmaceutical formulation adapted for administration by injection containing the compound 7α-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17β-diol, more particularly to a formulation adapted for administration by injection containing the compound 7α-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17β-diol in solution in a ricinoleate vehicle which additionally comprises at least one alcohol and a non-aqueous ester solvent which is miscible in the ricinoleate vehicle.